UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549





(Check One):   [_]  Form 10-K    [_]  Form 20-F    [_]  Form 11-K
               [X]   Form 10-Q   [_]  Form N-SAR

For Period Ended: December 31, 2000

[  ]    Transition Report on Form 10-K
[  ]    Transition Report on Form 20-F
[  ]    Transition Report on Form 11-K
[  ]    Transition Report on Form 10-Q
[  ]    Transition Report on Form N-SAR

For the Transition Period Ended:

- ------------------------------------------------------------------------------
  Read Instruction (on back page) Before Preparing Form. Please Print or Type.
    Nothing in this form shall be construed to imply that the Commissions has
                   verified any information contained herein.
- ------------------------------------------------------------------------------

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Full Name of Registrant:

Luna Medical Technologies, Inc.

Former Name if Applicable:

- ------------------------------------------------------------------------------

Address of Principal Executive Office (Street and Number)

c/o Suite 527, 999 Canada Place

City, State and  Zip Code

Vancouver, British Columbia, Canada V6C 3E1

PART II - Rules 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box, if appropriate)

     (a)  The reasons  described in  reasonable  detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

|X|  (b)  The subject annual report,  semi-annual  report,  transition report on
          Form 10-K, Form 20-F,  11-K, Form N-SAR, or portion  thereof,  will be
          filed on or before the fifteenth  calendar day following the prescribe
          due date; or the subject quarterly report of transition report on Form
          10-Q, or portion thereof will be filed on or before the fifth calendar
          day following the prescribed due date; and

     (b)  The accountant's statement or other exhibit required by Rule 12b-25(c)
          has been attached if applicable.



<PAGE>


PART III - NARRATIVE

State below in  reasonable  detail the reasons  why the Form 10-K,  11-K,  10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed).

Certian banking information is required before we can finalize financial
statements.


PART IV - OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification.

     Tracey St. Denis         (604)                         682-8439
       (Name)               (Area Code)                 (Telephone Number)

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities and Exchange Act of 1934 or Section 30 of the Investment Company
     Act of 1940 during the preceding 12 months or for such shorter  period that
     the  registrant  was  required to file such  report(s)  been filed?  If the
     answer is no, identify report(s).     [X]  Yes   [  ]  No

- ------------------------------------------------------------------------------

- ------------------------------------------------------------------------------

- ------------------------------------------------------------------------------

Luna Medical Technologies, Inc. has caused this notification to be signed on its
behalf by the undersigned,  Thereunto duly authorized, in the City of Vancouver,
British Columbia, Canada, on February 14, 2000.

                                              Luna Medical Technologies, Inc.,
                                              a Nevada Corporation

                                              By:              /s/
                                                       ---------------------
                                                       Dr. James Swanney
                                              Its:     President


INSTRUCTION:  The form may be signed by an executive office of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

- ------------------------------------------------------------------------------
                                   ATTENTION:
            Intentional misstatements or omissions of fact constitute
               Federal Criminal Violations (See 18 U.S.C. 1001).
- ------------------------------------------------------------------------------